iptacopan
novartis
['dance']
dramatic phase iii trial data showing that iptacopan mono therapy (an oral proximal complement inhibitor) was far superior than standard therapy for pnh significant increase in hb, drop in retic and transfusion avoidance #ash22 practice changing? 
Pediatric Hematologist @CCMC, Asso. PD for the fellowship, and sometimes Gryffindor but sometimes Ravenclaw